PARK16 - Parkinson's Disease Locus 16

PARK16 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PARK16 - Parkinson's Disease Locus 16</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RAB7L1 (primary gene at locus)</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>RAB7B, Rab7-like protein 1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB7-like 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>493856</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109189</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q96NA5</td>
</tr>
<tr>
<td class="label">Locus</td>
<td>PARK16 (1q32)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Function</td>
</tr>
<tr>
<td class="label">RAB7L1</td>
<td>Rab GTPase, vesicular trafficking</td>
</tr>
<tr>
<td class="label">SLC45A3</td>
<td>Solute carrier, prostate-specific</td>
</tr>
<tr>
<td class="label">NUCKS1</td>
<td>Nuclear casein kinase substrate</td>
</tr>
<tr>
<td class="label">PM20D1</td>
<td>Peptidase/amino acid metabolism</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
<

PARK16 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PARK16 - Parkinson's Disease Locus 16</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>RAB7L1 (primary gene at locus)</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>RAB7B, Rab7-like protein 1</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>RAB7-like 1</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>493856</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000109189</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q96NA5</td>
</tr>
<tr>
<td class="label">Locus</td>
<td>PARK16 (1q32)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Function</td>
</tr>
<tr>
<td class="label">RAB7L1</td>
<td>Rab GTPase, vesicular trafficking</td>
</tr>
<tr>
<td class="label">SLC45A3</td>
<td>Solute carrier, prostate-specific</td>
</tr>
<tr>
<td class="label">NUCKS1</td>
<td>Nuclear casein kinase substrate</td>
</tr>
<tr>
<td class="label">PM20D1</td>
<td>Peptidase/amino acid metabolism</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cortex</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Testis</td>
<td>High</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Pathway</td>
<td>Role of RAB7L1</td>
</tr>
<tr>
<td class="label">Lysosomal function</td>
<td>Maintains lysosomal homeostasis</td>
</tr>
<tr>
<td class="label">Autophagy</td>
<td>Required for autophagosome formation</td>
</tr>
<tr>
<td class="label">Protein sorting</td>
<td>Coordinates intracellular trafficking</td>
</tr>
<tr>
<td class="label">Lipid metabolism</td>
<td>Regulates lipid trafficking</td>
</tr>
<tr>
<td class="label">LRRK2 interaction</td>
<td>Genetic/functional interaction</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>

Introduction

PARK16 (Parkinson's Disease Locus 16) was first identified as a significant genetic risk factor for [Parkinson's disease](/diseases/parkinsons-disease) in a genome-wide association study (GWAS) meta-analysis published in 2010. [@satake2009] This locus on chromosome 1q32 spans approximately 200 kb and contains multiple genes, of which RAB7L1 (Rab7-like 1) has emerged as the primary effector gene mediating PD risk. The locus represents one of the most robust and consistently replicated PD risk loci discovered through GWAS.

The identification of PARK16 provided important insights into the pathogenesis of PD, highlighting the role of lysosomal trafficking, autophagy, and protein homeostasis in dopaminergic neuron survival. Subsequent research has demonstrated that RAB7L1 interacts genetically and functionally with [LRRK2](/genes/lrrk2), another major PD risk gene, providing a mechanistic link between two important PD pathways. [@takanashi2013]

Gene Overview

Genes at the PARK16 Locus

The PARK16 locus contains multiple genes:

RAB7L1 is considered the primary effector gene due to its brain expression and functional studies.

Protein Structure and Function

RAB7L1 Protein

RAB7L1 is a ~220 amino acid protein belonging to the Rab GTPase family:

Structural Features

• Rab GTPase domain: Core catalytic domain (~200 aa)
• GTP/GDP binding motifs: Switch I and II regions
• C-terminal prenylation site: CAAX motif for membrane localization
• Hypervariable region: Target specificity determinants

• GDP-bound state: Cytosolic, inactive
• GTP-bound state: Membrane-associated, active
• GDI displacement: GDP dissociation inhibitor
• GEF activation: Guanine nucleotide exchange factor

Molecular Functions

Vesicular Trafficking

• Regulates trafficking between Golgi and endosomes
• Controls late endosomal/lysosomal pathway
• Coordinates endocytic and secretory pathways
• Maintains retromer complex function

• Essential for autophagosome formation
• Coordinates autophagosome-lysosome fusion
• Modulates lysosomal function
• Controls protein clearance pathways [@kuwahara2022]

• Maintains lysosomal homeostasis
• Regulates lysosomal membrane dynamics
• Coordinates lipid trafficking
• Supports lysosomal degradation capacity

Expression Pattern

Cellular Localization

• Golgi apparatus: Primary localization
• Endosomes: Dynamic localization
• Lysosomes: Upon activation
• Cytosol: Inactive pool

Normal Physiological Function

Neuronal Functions

Protein Homeostasis

• Maintains neuronal protein quality control
• Coordinates synthesis, trafficking, and degradation
• Prevents accumulation of misfolded proteins
• Supports dendritic and axonal trafficking

• RAB7L1 is essential for autophagosome formation
• Coordinates maturation and fusion with lysosomes
• Maintains cellular clearance capacity
• Prevents toxic protein aggregation

• Regulates lysosomal pH and enzyme activity
• Controls lysosomal membrane dynamics
• Coordinates lipid and protein trafficking
• Maintains neuronal metabolic homeostasis

Cell-Type Specific Functions

Dopaminergic Neurons

• Particularly vulnerable to RAB7L1 dysfunction
• Supports survival in substantia nigra
• Coordinates protein clearance in long axons
• Maintains synaptic vesicle dynamics

• Supports general neuronal protein homeostasis
• Important for dendritic arbor maintenance
• Modulates axonal transport

Disease Associations

Parkinson's Disease

PARK16 is one of the most significant PD risk loci:

Genetic Association

• GWAS-identified variant: rs823118 (RAB7L1)
• Odds ratio: ~1.3-1.5 per risk allele
• Population-specific effects observed
• Consistent replication across cohorts [@international2011]

LRRK2 Interaction
RAB7L1 directly interacts with [LRRK2](/genes/lrrk2), the most common genetic cause of PD:

• LRRK2 phosphorylates RAB7L1
• RAB7L1 modulates LRRK2 activity
• Combined dysfunction accelerates neurodegeneration [@macleod2013]
• May explain synergistic genetic effects

Mechanisms of Neurodegeneration

Impaired Protein Clearance

• Autophagy-lysosomal pathway dysfunction
• Accumulation of [α-synuclein](/proteins/alpha-synuclein) aggregates
• Impaired clearance of damaged proteins
• Endoplasmic reticulum stress

• Reduced lysosomal degradative capacity
• Altered lysosomal pH and enzyme activity
• Lipid accumulation in neurons
• Impaired cellular clearance

• Age-dependent degeneration
• Axonal maintenance deficits
• Synaptic dysfunction
• Mitochondrial stress

Other Neurological Associations

• Essential tremor: Some association reported
• Alzheimer's disease: Possible interaction with amyloid pathology
• Aging: Age-dependent RAB7L1 dysfunction

Signaling and Interaction Network

Therapeutic Implications

Drug Development

RAB7L1-Targeted Approaches

• Small molecule activators: Enhance RAB7L1 function
• Gene therapy: Viral vector-mediated expression
• Protein replacement: Direct protein delivery

• LRRK2 inhibitors: May benefit PARK16 carriers
• Autophagy enhancers: Compensate for RAB7L1 dysfunction
• Lysosomal modulators: Improve clearance capacity

Challenges

Biomarker Potential

• RAB7L1 expression as PD progression marker
• Genetic testing for PARK16 risk variants
• Lysosomal function assays
• Autophagy biomarkers

Research Directions

Current Areas of Investigation

Key Unanswered Questions

• What is the precise molecular mechanism of RAB7L1 dysfunction in PD?
• Can RAB7L1 modulation slow or reverse neurodegeneration?
• What is the optimal timing for intervention?
• How does RAB7L1 interact with other PD risk genes?

See Also

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [LRRK2 Gene](/genes/lrrk2)
• [RAB Proteins](/mechanisms/vesicular-trafficking)
• [Alpha-Synuclein](/proteins/alpha-synuclein)
• [Autophagy](/mechanisms/autophagy)
• [Lysosomal Dysfunction](/mechanisms/lysosomal-dysfunction)
• [Retromer Complex](/proteins/retromer-complex)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving PARK16 - Parkinson's Disease Locus 16 discovered through SciDEX knowledge graph analysis: